Company / PP&E per Share
Catalyst Pharmaceuticals Partners, Inc. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.01
FY2025
5-year range
$0.01 / $0.01
FY2021-FY2025
Trend
-24.4%
vs FY2024
Sector context
#166 of 193
Health Care
What the data says
Catalyst Pharmaceuticals Partners, Inc.'s pp&e per share of $0.01 is lower than 86% of companies in the Health Care sector (FY2025). PP&E per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2020 to $0.01 in FY2024.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of +46.4%.
Declined from $0.01 to $0.01 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +1.7%
- 5-Year CAGR
- +46.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 193This company $0.01 Sector average $22.13
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share decreased 24.4% year-over-year.
- Ranks #166 out of 193 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2024.
- Lowest pp&e per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -24.4% |
| FY2024 | $0.01 | +0.4% |
| FY2023 | $0.01 | +38.6% |
| FY2022 | $0.01 | -13.6% |
| FY2021 | $0.01 | +640.6% |
| FY2020 | $0.00 | -38.6% |
| FY2019 | $0.00 | -14.4% |
| FY2018 | $0.00 | +3.8% |
| FY2017 | $0.00 | -21.6% |
| FY2016 | $0.00 | +27.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026